Sars-cov-2 Acute Respiratory Disease
📧 Sign up to get email alerts when something new happens for Sars-cov-2 Acute Respiratory Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) [Phase 2]
Phase 2 clinical trial update reporting safety and immunogenicity of a recombinant protein RBD fusion dimer vaccine targeting SARS-CoV-2 for…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2 [Phase 4]
A Phase 4 clinical trial evaluating povidone iodine nasal application to prevent intraoperative spread of SARS-CoV-2 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: NAC for Attenuation of COVID-19 Symptomatology [Phase 2]
A Phase 2 clinical trial is updating on N-acetylcysteine (NAC) for attenuation of COVID-19 symptomatology, with various COVID-19-related res…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19. [Phase 3]
A Phase III trial evaluating the safety and immunogenicity of Hipra's candidate booster for COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19. [Phase 2]
Phase 2 study assessing immunogenicity and safety of Hipra's booster vaccination in adults previously vaccinated with an adenovirus COVID-19…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: SOLIDARITY Finland Plus Long-COVID [Phase 4]
Phase 4 clinical trial update for SOLIDARITY Finland Plus Long-COVID is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
A completed clinical trial evaluating a pandemic triage score for patients with known or suspected SARS-CoV-2 infection; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray [Phase 1, Phase 2]
Phase 1/2 trial update on safety, tolerability, and immunogenicity of Gam-COVID-Vac delivered as a nasal spray.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals [Phase 2]
Phase 2 clinical trial update evaluating reconvalescent plasma and camostat mesylate started early in SARS-CoV-2 positive high-risk individu…
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients [Phase 2]
Phase 2 exploratory trial evaluating basiliximab for pulmonary cytokine storm in hospitalized adults with SARS-CoV-2 infection.